Journal of Comprehensive Pediatrics

Published by: Kowsar

The Prevalence and Incidence of Atypical Hemolytic Uremic Syndrome in Iran: A Systematic Review and Meta-Analysis Protocol Study

Nakysa Hooman 1 , * , Mahnaz Sadeghian 2 , Fariba Jahangiri 3 and Soudabeh Hosseini 4
Authors Information
1 Ali-Asghar Clinical Research Development Center, Iran University of Medical Sciences, Tehran, Iran
2 Department of Pediatric Gastroenterology, Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran
3 Department of Pediatric Surgery, Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran
4 Department of Laboratory, Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Comprehensive Pediatrics: February 2018, 9 (1); e56080
  • Published Online: November 27, 2017
  • Article Type: Review Article
  • Received: June 24, 2017
  • Revised: August 25, 2017
  • Accepted: November 6, 2017
  • DOI: 10.5812/compreped.56080

To Cite: Hooman N, Sadeghian M, Jahangiri F, Hosseini S. The Prevalence and Incidence of Atypical Hemolytic Uremic Syndrome in Iran: A Systematic Review and Meta-Analysis Protocol Study, J Compr Ped. 2018 ;9(1):e56080. doi: 10.5812/compreped.56080.

Abstract
Copyright © 2017, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Context
2. Research Question and Analytic Framework
3. Protocol and Registration
4. Eligibility Criteria
5. Types of Participants
6. Data Source and Search Strategy
7. Provisional Search Strategy for Pubmed
8. Study Selection
9. Data Extraction and Risk of Bias Assessment
10. Data Synthesis and Statistical Analysis
11. Discussion
12. Implication for Health Policy, Practice, Research, and Medical Education
Acknowledgements
Footnote
References
  • 1. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(19):1847-8. doi: 10.1056/NEJMc1410951. [PubMed: 25372103].
  • 2. Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2008;23(11):1957-72. doi: 10.1007/s00467-008-0872-4. [PubMed: 18594873].
  • 3. Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, et al. An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol. 2014;29(10):1967-78. doi: 10.1007/s00467-014-2817-4. [PubMed: 24817340].
  • 4. Fakhouri F, Zuber J, Fremeaux Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681-96. doi: 10.1016/S0140-6736(17)30062-4. [PubMed: 28242109].
  • 5. Berger BE. The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome. Am J Med Sci. 2016;352(2):177-90. doi: 10.1016/j.amjms.2016.05.003. [PubMed: 27524217].
  • 6. Hooman N. Acute kidney injury in Iranian children, what do we know about It? Part 2. J Ped Nephrology. 2014;2(3):98-103.
  • 7. Otukesh H, Hoseini R, Hooman N, Chalian M, Chalian H, Tabarroki A. Prognosis of acute renal failure in children. Pediatr Nephrol. 2006;21(12):1873-8. doi: 10.1007/s00467-006-0240-1. [PubMed: 16960713].
  • 8. Akhavan Sepahi M, Derakhshan A, Sharifian M, Shajari A. Hemolytic uremic syndrome; report of a case with late recovery of renal function. Qom Univ Med Sci J. 2008;2(1):67-71.
  • 9. Otukesh H, Hoseini R, Golnari P, Fereshtehnejad SM, Zamanfar D, Hooman N, et al. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children. J Nephrol. 2008;21(5):694-703. [PubMed: 18949724].
  • 10. Ataei N, Kheradmand K, Madani A, Mohseni P, Esfehan ST, Khodadad A. The Importance of some prognostic factors in children with hemolytic uremic syndrome in children medical center from 1982 to 2002. Tehran Univ Med J. 2004;62(11):888-93.
  • 11. Hooman N, Otoukesh H, Talachian E, Hallaji F, Mehrazma M. Common bile duct stone associated with hemolytic uremic syndrome. Arch Iran Med. 2007;10(3):401-3. [PubMed: 17604484].
  • 12. Esfandiar N, Alaei F, Sharifian M, Alaei M, Dalirani R, Khalilian MR. Dilated cardiomyopathy several months after hemolytic uremic syndrome. J Pediatr Nephrol. 2016;4(1):45-8. doi: 10.20286/jpn-040145.
  • 13. Javadilarijani F, Sayarifard A, Javadilarijani F, Ataei N, Pajouhi A. Typical hemolytic uremic syndrome with diffused brain ischemia as a complication, a case report of a child in Iran. J Ped Nephrology. 2014;2(1):39-42.
  • 14. Hooman N, Otukesh H, Delshad S, Farhood P. Surgical complications of hemolytic uremic syndrome, single center experiences. J Indian Assoc Pediatr Surg. 2007;12(3):129. doi: 10.4103/0971-9261.34950.
  • 15. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035-50. doi: 10.1681/ASN.2004100861. [PubMed: 15728781].
  • 16. Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis. 2014;14:265. doi: 10.1186/1471-2334-14-265. [PubMed: 24884396].
  • 17. Miller DP, Kaye JA, Shea K, Ziyadeh N, Cali C, Black C, et al. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology. 2004;15(2):208-15. [PubMed: 15127914].
  • 18. Zimmerhackl LB, Besbas N, Jungraithmayr T, Van de Kar N, Karch H, Karpman D, et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost. 2006;32(2):113-20. doi: 10.1055/s-2006-939767. [PubMed: 16575686].
  • 19. Karimi M, Sabzi A, Peyvandi F, Mannucci PM. Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran. J Thromb Haemost. 2006;4(3):701-2. doi: 10.1111/j.1538-7836.2006.01807.x. [PubMed: 16460465].
  • 20. Mehrazma M, Hooman N, Otukesh H. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome. Iran J Kidney Dis. 2011;5(6):380-5. [PubMed: 22057069].
  • 21. Hooman N, Sadeghian M, Jahangiri F, Hosseini S. The incidence and prevalence of hemolytic uremic syndrome in Iran, PROSPERO 2017. Iran: PROSPERO; 2017. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017059086.
  • 22. Hooman N, Mansour Ghanaei R, Yaghoubi M, Nakhaie S. The prevalence of shiga toxin producing escherichia coli in patients with gasteroenteritis and sources of infections in Iran, a systematic review study protocol. J Ped Nephrology. 2016;4(3):82-5.
  • 23. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-7. [PubMed: 17938396].
  • 24. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934-9. doi: 10.1016/j.jclinepi.2011.11.014. [PubMed: 22742910].
  • 25. DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139-45. doi: 10.1016/j.cct.2015.09.002. [PubMed: 26343745].
  • 26. Jokiranta TS. HUS and atypical HUS. Blood. 2017;129(21):2847-56. doi: 10.1182/blood-2016-11-709865. [PubMed: 28416508].
  • 27. Guillard T, Limelette A, Le Magrex-Debar E, Wynckel A, Gouali M, Mariani-Kurkdjian P, et al. Fatal case of hemolytic-uremic syndrome in an adult due to a rare serogroup O91 Entero hemorrhagic Escherichia coli associated with a Clostridium difficile infection. More than meets the eye. Int J Infect Dis. 2015;37:113-4. doi: 10.1016/j.ijid.2015.06.015. [PubMed: 26135847].
  • 28. Hong JY, Jung JY, Kang YA, Bae YS, Kim YS, Kim SK, et al. Delayed hemolytic uremic syndrome presenting as diffuse alveolar hemorrhage. Korean J Crit Care Med. 2014;29(1):43. doi: 10.4266/kjccm.2014.29.1.43.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments